DE2550395C3 - lO.ll-Dihydro-S-carboxycyproheptadin - Google Patents

lO.ll-Dihydro-S-carboxycyproheptadin

Info

Publication number
DE2550395C3
DE2550395C3 DE2550395A DE2550395A DE2550395C3 DE 2550395 C3 DE2550395 C3 DE 2550395C3 DE 2550395 A DE2550395 A DE 2550395A DE 2550395 A DE2550395 A DE 2550395A DE 2550395 C3 DE2550395 C3 DE 2550395C3
Authority
DE
Germany
Prior art keywords
dihydro
compound
methyl
dibenzo
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2550395A
Other languages
German (de)
English (en)
Other versions
DE2550395A1 (de
DE2550395B2 (de
Inventor
David Carroll North Wales Pa. Remy (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2550395A1 publication Critical patent/DE2550395A1/de
Publication of DE2550395B2 publication Critical patent/DE2550395B2/de
Application granted granted Critical
Publication of DE2550395C3 publication Critical patent/DE2550395C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
DE2550395A 1974-11-11 1975-11-10 lO.ll-Dihydro-S-carboxycyproheptadin Expired DE2550395C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52267674A 1974-11-11 1974-11-11
US56328575A 1975-03-28 1975-03-28

Publications (3)

Publication Number Publication Date
DE2550395A1 DE2550395A1 (de) 1976-05-13
DE2550395B2 DE2550395B2 (de) 1978-11-30
DE2550395C3 true DE2550395C3 (de) 1979-08-09

Family

ID=27060901

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2550395A Expired DE2550395C3 (de) 1974-11-11 1975-11-10 lO.ll-Dihydro-S-carboxycyproheptadin

Country Status (19)

Country Link
JP (1) JPS6011029B2 (es)
AR (1) AR211108A1 (es)
AT (1) AT352126B (es)
CA (1) CA1082177A (es)
CH (1) CH621114A5 (es)
DE (1) DE2550395C3 (es)
DK (1) DK474575A (es)
ES (1) ES442375A1 (es)
FI (1) FI59583C (es)
FR (1) FR2290203A1 (es)
IE (1) IE42220B1 (es)
IL (1) IL48365A (es)
LU (1) LU73771A1 (es)
NL (2) NL173398B (es)
NO (1) NO144422C (es)
NZ (1) NZ179080A (es)
PH (1) PH13443A (es)
SE (1) SE424990B (es)
YU (1) YU273475A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195091A (en) * 1978-11-15 1980-03-25 Merck & Co., Inc. Appetite stimulating pyrrolo[2,1-b][3]benzazepines
US4412999A (en) * 1982-04-14 1983-11-01 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same

Also Published As

Publication number Publication date
ES442375A1 (es) 1977-08-16
NO144422C (no) 1981-08-26
FI59583C (fi) 1981-09-10
ATA843975A (de) 1979-02-15
FI752920A (es) 1976-05-12
CH621114A5 (en) 1981-01-15
AU8605775A (en) 1977-05-05
NL173398C (nl)
DE2550395A1 (de) 1976-05-13
CA1082177A (en) 1980-07-22
IL48365A (en) 1978-10-31
NL7512384A (nl) 1976-05-13
NL173398B (nl) 1983-08-16
LU73771A1 (es) 1976-09-06
PH13443A (en) 1980-04-23
FR2290203B1 (es) 1980-05-30
IL48365A0 (en) 1975-12-31
AR211108A1 (es) 1977-10-31
NO144422B (no) 1981-05-18
NO753562L (es) 1976-05-12
IE42220L (en) 1976-05-11
NZ179080A (en) 1978-07-10
YU273475A (en) 1983-04-27
DE2550395B2 (de) 1978-11-30
SE424990B (sv) 1982-08-23
JPS5170769A (en) 1976-06-18
FI59583B (fi) 1981-05-29
SE7511792L (sv) 1976-05-12
FR2290203A1 (fr) 1976-06-04
JPS6011029B2 (ja) 1985-03-22
IE42220B1 (en) 1980-07-02
AT352126B (de) 1979-09-10
DK474575A (da) 1976-05-12

Similar Documents

Publication Publication Date Title
DE2824064A1 (de) Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel
DE2536206C2 (de) 3-Chinolincarbonsäure-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE2065636C3 (de) Tricyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DD216716A5 (de) Verfahren zur herstellung von octahydrobenzo (f)chinolinen
DE2522553A1 (de) Eckige klammer auf 1-hydroximino- 2,2-disubstituiert-5-indanyloxy(oder thio) eckige klammer zu alkansaeuren und verfahren zu ihrer herstellung
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
DE3016752C2 (es)
DE2723051C3 (de) NKAcyO-p-amino-NMn-decyl- und n-tridecyl)-benzamide sowie diese enthaltende Arzneimittel
DE2550395C3 (de) lO.ll-Dihydro-S-carboxycyproheptadin
DE3007710C2 (de) 5,6;8,9-Tetrahydro-7H-dibenz(d,f)azonin-derivate, Verfahren zu deren Herstellung und Arzneimittel
DE2026080C3 (de) 5-Methyl-10-( ß -alkylaminoäthyl)- dibenzothiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Zusammensetzungen
DE2107871C3 (es)
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE1962442C3 (de) 2-Benzoylalkylbenzomorphane, Verfahren zu ihrer Herstellung und Arzneimittel
DE2322561A1 (de) Trisubstituierte imidazole
DE2657950A1 (de) Trifluormethylthioderivate von cyproheptadin
DE2903917C2 (es)
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
AT360990B (de) Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- -cyclohepten-5-yliden)-piperidin (10,11-dihydro -3-carboxy-cyproheptadin), seines n-oxids und seiner salze
AT360016B (de) Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- cyclohepten-5-yliden)-piperidin (10,11-dihydro- -3-carboxy-cyproheptadin), seines n-oxids und seiner salze
DE2717062A1 (de) Arzneimittel mit antitussiver wirkung
AT360017B (de) Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- -cyclohepten-5-yliden)-piperidin (10,11-dihydro -3-carboxy-cyproheptadin), seines n-oxids und seiner salze
DE1595870A1 (de) Verfahren zur Herstellung von 3-(o-Methoxyphenoxy)-1,2-propandiolnicotinaten und deren Salzen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee